Thrivent Financial for Lutherans Has $400,000 Holdings in Molina Healthcare, Inc $MOH

Thrivent Financial for Lutherans decreased its holdings in Molina Healthcare, Inc (NYSE:MOH) by 72.9% during the third quarter, Holdings Channel.com reports. The firm owned 2,088 shares of the company’s stock after selling 5,630 shares during the period. Thrivent Financial for Lutherans’ holdings in Molina Healthcare were worth $400,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. Centric Wealth Management grew its position in Molina Healthcare by 21.4% during the third quarter. Centric Wealth Management now owns 12,084 shares of the company’s stock valued at $2,312,000 after purchasing an additional 2,128 shares in the last quarter. National Pension Service lifted its position in Molina Healthcare by 24.1% in the 3rd quarter. National Pension Service now owns 23,372 shares of the company’s stock worth $4,472,000 after buying an additional 4,534 shares in the last quarter. Scion Asset Management LLC acquired a new stake in shares of Molina Healthcare during the 3rd quarter valued at $23,920,000. SYM FINANCIAL Corp grew its holdings in shares of Molina Healthcare by 74.5% during the 3rd quarter. SYM FINANCIAL Corp now owns 1,904 shares of the company’s stock valued at $364,000 after acquiring an additional 813 shares in the last quarter. Finally, New York State Common Retirement Fund increased its stake in shares of Molina Healthcare by 35.9% in the third quarter. New York State Common Retirement Fund now owns 139,557 shares of the company’s stock worth $26,706,000 after acquiring an additional 36,831 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Richard M. Schapiro sold 357 shares of the firm’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $143.02, for a total value of $51,058.14. Following the sale, the director owned 11,352 shares of the company’s stock, valued at $1,623,563.04. This trade represents a 3.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 1.26% of the company’s stock.

Molina Healthcare Price Performance

NYSE MOH opened at $135.42 on Wednesday. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $359.97. The company has a fifty day simple moving average of $170.25 and a 200 day simple moving average of $169.18. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.97. The company has a market cap of $6.97 billion, a P/E ratio of 15.82 and a beta of 0.49.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The firm had revenue of $11.38 billion during the quarter, compared to the consensus estimate of $10.90 billion. During the same quarter last year, the business earned $5.05 EPS. The business’s revenue was up 8.3% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, sell-side analysts predict that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Analyst Ratings Changes

A number of analysts recently issued reports on MOH shares. TD Cowen reduced their price objective on Molina Healthcare from $175.00 to $144.00 and set a “hold” rating for the company in a research report on Monday, February 9th. UBS Group reaffirmed a “neutral” rating and set a $145.00 price target on shares of Molina Healthcare in a research note on Monday, February 9th. Barclays lowered their price target on Molina Healthcare from $164.00 to $133.00 and set an “underweight” rating for the company in a research note on Tuesday, February 10th. Weiss Ratings restated a “sell (d+)” rating on shares of Molina Healthcare in a report on Thursday, January 22nd. Finally, Jefferies Financial Group set a $160.00 target price on shares of Molina Healthcare in a research note on Tuesday, December 16th. Three equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $162.64.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.